Literature DB >> 30719682

Effects of Catheterization on Artery Function and Health: When Should Patients Start Exercising Following Their Coronary Intervention?

Andrea Tryfonos1, Daniel J Green2, Ellen A Dawson3.   

Abstract

Coronary artery disease (CAD) is a leading cause of death worldwide, and percutaneous transluminal coronary angiography (PTCA) and/or percutaneous coronary intervention (PCI; angioplasty) are commonly used to diagnose and/or treat the obstructed coronaries. Exercise-based rehabilitation is recommended for all CAD patients; however, most guidelines do not specify when exercise training should commence following PTCA and/or PCI. Catheterization can result in arterial dysfunction and acute injury, and given the fact that exercise, particularly at higher intensities, is associated with elevated inflammatory and oxidative stress, endothelial dysfunction and a pro-thrombotic milieu, performing exercise post-PTCA/PCI may transiently elevate the risk of cardiac events. This review aims to summarize extant literature relating to the impacts of coronary interventions on arterial function, including the time-course of recovery and the potential deleterious and/or beneficial impacts of acute versus long-term exercise. The current literature suggests that arterial dysfunction induced by catheterization recovers 4-12 weeks following catheterization. This review proposes that a period of relative arterial vulnerability may exist and exercise during this period may contribute to elevated event susceptibility. We therefore suggest that CAD patients start an exercise training programme between 2 and 4 weeks post-PCI, recognizing that the literature suggest there is a 'grey area' for functional recovery between 2 and 12 weeks post-catheterization. The timing of exercise onset should take into consideration the individual characteristics of patients (age, severity of disease, comorbidities) and the intensity, frequency and duration of the exercise prescription.

Entities:  

Mesh:

Year:  2019        PMID: 30719682     DOI: 10.1007/s40279-019-01055-3

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  253 in total

Review 1.  Nitric oxide and the proliferation of vascular smooth muscle cells.

Authors:  J Y Jeremy; D Rowe; A M Emsley; A C Newby
Journal:  Cardiovasc Res       Date:  1999-08-15       Impact factor: 10.787

2.  Losartan, an angiotensin type 1 receptor inhibitor, and endothelial vasodilator function in Type 1 diabetes mellitus.

Authors:  J Collis; C Cheetham; L Dembo; J O'Driscoll; K Stanton; R Taylor; D Green
Journal:  Diabet Med       Date:  2000-07       Impact factor: 4.359

3.  Evidence for prothrombotic effects of exercise and limited protection by aspirin.

Authors:  N Li; N H Wallén; P Hjemdahl
Journal:  Circulation       Date:  1999-09-28       Impact factor: 29.690

4.  Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus.

Authors:  G O'Driscoll; D Green; A Maiorana; K Stanton; F Colreavy; R Taylor
Journal:  J Am Coll Cardiol       Date:  1999-05       Impact factor: 24.094

5.  The impact of coronary artery disease on the coronary vasomotor response to nonionic contrast media.

Authors:  U Limbruno; A S Petronio; G Amoroso; R Baglini; G Paterni; A Merelli; R Mariotti; M Mariani
Journal:  Circulation       Date:  2000-02-08       Impact factor: 29.690

6.  Effect of exercise on coronary endothelial function in patients with coronary artery disease.

Authors:  R Hambrecht; A Wolf; S Gielen; A Linke; J Hofer; S Erbs; N Schoene; G Schuler
Journal:  N Engl J Med       Date:  2000-02-17       Impact factor: 91.245

7.  Losartan, an angiotensin type I receptor antagonist, improves conduit vessel endothelial function in Type II diabetes.

Authors:  C Cheetham; G O'Driscoll; K Stanton; R Taylor; D Green
Journal:  Clin Sci (Lond)       Date:  2001-01       Impact factor: 6.124

8.  Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes.

Authors:  C Cheetham; J Collis; G O'Driscoll; K Stanton; R Taylor; D Green
Journal:  J Am Coll Cardiol       Date:  2000-11-01       Impact factor: 24.094

9.  Ultrasonic assessment of vascular complications in coronary angiography and angioplasty after transradial approach.

Authors:  S Nagai; S Abe; T Sato; K Hozawa; K Yuki; K Hanashima; H Tomoike
Journal:  Am J Cardiol       Date:  1999-01-15       Impact factor: 2.778

Review 10.  Oxidative stress as a signaling mechanism of the vascular response to injury: the redox hypothesis of restenosis.

Authors:  L C Azevedo; M A Pedro; L C Souza; H P de Souza; M Janiszewski; P L da Luz; F R Laurindo
Journal:  Cardiovasc Res       Date:  2000-08-18       Impact factor: 10.787

View more
  1 in total

1.  Effect of Exercise Prescription Implementation Rate on Cardiovascular Events.

Authors:  Li-Yue Zhu; Min-Yan Li; Kun-Hui Li; Xiao Yang; Yi-Yong Yang; Xiao-Xia Zhao; Ting Yan; Meng-Meng Li; Si-Qi Luo; Mu-Lan Zhang; Jin-Zi Su
Journal:  Front Cardiovasc Med       Date:  2022-02-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.